BPC-157

A synthetic pentadecapeptide derived from a protein in gastric juice, widely studied in animal models for soft-tissue healing, gut integrity and blood-vessel growth.

What it is

BPC-157 is a short, stable peptide originally identified as a fragment of a protective protein found in the stomach. Because it's so compact, researchers have used it as a reference compound when studying how the body repairs itself.

How it's thought to work

The most-discussed idea is that BPC-157 may promote angiogenesis — the growth of new blood vessels — which helps deliver oxygen and nutrients to damaged tissue. It also appears to influence growth-factor signalling and nitric-oxide pathways in laboratory models, both of which are central to wound healing.

Potential health benefits

In preclinical research, BPC-157 has been studied for:

Tendon, ligament and muscle recovery after injury.
Gut integrity — protecting and repairing the intestinal lining.
Joint comfort and mobility in models of inflammation.

These are areas of active investigation rather than proven outcomes in people.

What the research says

Most BPC-157 data comes from rodent studies, where results have been consistently encouraging across many tissue types. Robust human clinical trials are still lacking, so the human dose, safety profile and real-world effectiveness remain uncertain.

Considerations

BPC-157 is not approved as a therapeutic in most countries. Anyone considering it should understand the limited human evidence and speak with a qualified healthcare professional first.